It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Neurons are highly compartmentalized cells with tightly controlled subcellular protein organization. While brain transcriptome, connectome and global proteome maps are being generated, system-wide analysis of temporal protein dynamics at the subcellular level are currently lacking. Here, we perform a temporally-resolved surfaceome analysis of primary neuron cultures and reveal dynamic surface protein clusters that reflect the functional requirements during distinct stages of neuronal development. Direct comparison of surface and total protein pools during development and homeostatic synaptic scaling demonstrates system-wide proteostasis-independent remodeling of the neuronal surface, illustrating widespread regulation on the level of surface trafficking. Finally, quantitative analysis of the neuronal surface during chemical long-term potentiation (cLTP) reveals fast externalization of diverse classes of surface proteins beyond the AMPA receptor, providing avenues to investigate the requirement of exocytosis for LTP. Our resource (neurosurfaceome.ethz.ch) highlights the importance of subcellular resolution for systems-level understanding of cellular processes.
Cell surface proteins contribute to neuronal development and activity-dependent synaptic plasticity. Here, the authors perform a time-resolved surfaceome analysis of developing primary neurons and in response to homeostatic synaptic scaling and chemical long-term potentiation (cLTP), revealing surface proteome remodeling largely independent of global proteostasis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Neuroscience Center Zurich, Zurich, Switzerland; ETH Zurich, Institute of Translational Medicine (ITM), Department of Health Sciences and Technology, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780); Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland (GRID:grid.419765.8) (ISNI:0000 0001 2223 3006)
2 Neuroscience Center Zurich, Zurich, Switzerland (GRID:grid.419765.8); University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
3 Neuroscience Center Zurich, Zurich, Switzerland (GRID:grid.7400.3); University of Zurich, Laboratory of Neural Connectivity, Faculties of Medicine and Natural Sciences, Brain Research Institute, Zürich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
4 ETH Zurich, Institute of Translational Medicine (ITM), Department of Health Sciences and Technology, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780); Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland (GRID:grid.419765.8) (ISNI:0000 0001 2223 3006)
5 Max Planck Institute for Brain Research, Frankfurt, Germany (GRID:grid.419505.c) (ISNI:0000 0004 0491 3878)
6 ETH Zurich, Institute of Translational Medicine (ITM), Department of Health Sciences and Technology, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
7 Neuroscience Center Zurich, Zurich, Switzerland (GRID:grid.419765.8); University of Zurich, Laboratory of Neural Connectivity, Faculties of Medicine and Natural Sciences, Brain Research Institute, Zürich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
8 Neuroscience Center Zurich, Zurich, Switzerland (GRID:grid.7400.3); University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
9 Neuroscience Center Zurich, Zurich, Switzerland (GRID:grid.7400.3); ETH Zurich, Institute of Translational Medicine (ITM), Department of Health Sciences and Technology, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780); Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland (GRID:grid.419765.8) (ISNI:0000 0001 2223 3006)